XML 29 R19.htm IDEA: XBRL DOCUMENT v3.4.0.3

Revenues (Tables)

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three months ended March 31, 2016 and 2015:

	Three months ended March 31,
	2016				2015
Products:
Acetadote	$	1,837,462			$	1,543,009
Omeclamox-Pak	760,319				758,191
Kristalose	3,617,806				4,098,778
Vaprisol	368,047				1,023,990
Caldolor	1,071,968				1,194,681
Other	81,930				68,125
Total net revenues	$	7,737,532			$	8,686,774

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration